These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 39082875)

  • 21. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.
    Acchioni C; Remoli AL; Marsili G; Acchioni M; Nardolillo I; Orsatti R; Farcomeni S; Palermo E; Perrotti E; Barreca ML; Sabatini S; Sandini S; Parolin C; Lin R; Borsetti A; Hiscott J; Sgarbanti M
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events.
    Lucera MB; Tilton CA; Mao H; Dobrowolski C; Tabler CO; Haqqani AA; Karn J; Tilton JC
    J Virol; 2014 Sep; 88(18):10803-12. PubMed ID: 25008921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apobec3A maintains HIV-1 latency through recruitment of epigenetic silencing machinery to the long terminal repeat.
    Taura M; Song E; Ho YC; Iwasaki A
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2282-2289. PubMed ID: 30670656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic Chromatin-Modifying Treatments Reactivate Latent HIV and Decrease Migration of Multiple Host-Cell Types.
    Blanco A; Mahajan T; Coronado RA; Ma K; Demma DR; Dar RD
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34201394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KDM5A/B contribute to HIV-1 latent infection and survival of HIV-1 infected cells.
    Li TW; Park Y; Watters EG; Wang X; Zhou D; Fiches GN; Wu Z; Badley AD; Sacha JB; Ho WZ; Santoso NG; Qi J; Zhu J
    Antiviral Res; 2024 Aug; 228():105947. PubMed ID: 38925368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.
    Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W
    J Virol; 2018 May; 92(9):. PubMed ID: 29491162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors.
    Perdigão P; Gaj T; Santa-Marta M; Barbas CF; Goncalves J
    PLoS One; 2016; 11(3):e0150037. PubMed ID: 26933881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb.
    Ma X; Yang T; Luo Y; Wu L; Jiang Y; Song Z; Pan T; Liu B; Liu G; Liu J; Yu F; He Z; Zhang W; Yang J; Liang L; Guan Y; Zhang X; Li L; Cai W; Tang X; Gao S; Deng K; Zhang H
    Elife; 2019 Jan; 8():. PubMed ID: 30652970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals.
    Trejbalová K; Kovářová D; Blažková J; Machala L; Jilich D; Weber J; Kučerová D; Vencálek O; Hirsch I; Hejnar J
    Clin Epigenetics; 2016; 8():19. PubMed ID: 26900410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-Induced Epigenetic Alterations in Host Cells.
    Abdel-Hameed EA; Ji H; Shata MT
    Adv Exp Med Biol; 2016; 879():27-38. PubMed ID: 26659262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quiescence Promotes Latent HIV Infection and Resistance to Reactivation from Latency with Histone Deacetylase Inhibitors.
    Painter MM; Zaikos TD; Collins KL
    J Virol; 2017 Dec; 91(24):. PubMed ID: 29021396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2.
    Friedman J; Cho WK; Chu CK; Keedy KS; Archin NM; Margolis DM; Karn J
    J Virol; 2011 Sep; 85(17):9078-89. PubMed ID: 21715480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An upstream YY1 binding site on the HIV-1 LTR contributes to latent infection.
    Bernhard W; Barreto K; Raithatha S; Sadowski I
    PLoS One; 2013; 8(10):e77052. PubMed ID: 24116200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diversity of small molecule HIV-1 latency reversing agents identified in low- and high-throughput small molecule screens.
    Hashemi P; Sadowski I
    Med Res Rev; 2020 May; 40(3):881-908. PubMed ID: 31608481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CpG methylation controls reactivation of HIV from latency.
    Blazkova J; Trejbalova K; Gondois-Rey F; Halfon P; Philibert P; Guiguen A; Verdin E; Olive D; Van Lint C; Hejnar J; Hirsch I
    PLoS Pathog; 2009 Aug; 5(8):e1000554. PubMed ID: 19696893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin.
    Romani B; Kamali Jamil R; Hamidi-Fard M; Rahimi P; Momen SB; Aghasadeghi MR; Allahbakhshi E
    Sci Rep; 2016 Aug; 6():31924. PubMed ID: 27550312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs.
    Abner E; Stoszko M; Zeng L; Chen HC; Izquierdo-Bouldstridge A; Konuma T; Zorita E; Fanunza E; Zhang Q; Mahmoudi T; Zhou MM; Filion GJ; Jordan A
    J Virol; 2018 May; 92(10):. PubMed ID: 29343578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A macrophage-cell model of HIV latency reveals the unusual importance of the bromodomain axis.
    Kisaka JK; Rauch D; Griffith M; Kyei GB
    Virol J; 2024 Apr; 21(1):80. PubMed ID: 38581045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scaffold attachment factor B suppresses HIV-1 infection of CD4
    Ma L; Sun L; Jin X; Xiong SD; Wang JH
    J Biol Chem; 2018 Aug; 293(31):12177-12185. PubMed ID: 29887524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.